Cargando…
Implementing targeted therapies in the treatment of glioblastoma: Previous shortcomings, future promises, and a multimodal strategy recommendation
The introduction of targeted therapies to the field of oncology has prolonged the survival of several tumor types. Despite extensive research and numerous trials, similar outcomes have unfortunately not been realized for glioblastoma. For more than 15 years, the standard treatment of glioblastoma ha...
Autores principales: | Fougner, Vincent, Hasselbalch, Benedikte, Lassen, Ulrik, Weischenfeldt, Joachim, Poulsen, Hans Skovgaard, Urup, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616055/ https://www.ncbi.nlm.nih.gov/pubmed/36325372 http://dx.doi.org/10.1093/noajnl/vdac157 |
Ejemplares similares
-
The impact of bevacizumab treatment on survival and quality of life in newly diagnosed glioblastoma patients
por: Poulsen, Hans Skovgaard, et al.
Publicado: (2014) -
A Prognostic Model for Glioblastoma Patients Treated With Standard Therapy Based on a Prospective Cohort of Consecutive Non-Selected Patients From a Single Institution
por: Abedi, Armita Armina, et al.
Publicado: (2021) -
Hallmarks of glioblastoma: a systematic review
por: Nørøxe, Dorte Schou, et al.
Publicado: (2017) -
Immunotherapy in Glioblastoma: Current Shortcomings and Future Perspectives
por: Weenink, Bas, et al.
Publicado: (2020) -
Tumor mutational burden and purity adjustment before and after treatment with temozolomide in 27 paired samples of glioblastoma: a prospective study
por: Schou Nørøxe, Dorte, et al.
Publicado: (2021)